Insiders VALBIOTIS

Equities

ALVAL

FR0013254851

Market Closed - Euronext Paris Other stock markets 11:35:12 2024-05-16 am EDT			5-day change	1st Jan Change
4.23 ^EUR	-2.87%		-8.04%	-15.40%

Apr. 26	Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 03	Valbiotis: launch of Valbiotis PRO Cholesterol in May	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valbiotis Appoints Frédéric PELONG to Board of Directors	22-09-06	CI
Valbiotis CFO To Step Down In June	22-03-03	MT
Valbiotis Announces Board of Directors Changes	22-03-03	CI
Valbiotis Appoints Sébastien Bessy as Chief Operating Marketing and Business Officer	21-06-07	CI
VALBIOTIS Appoints Agnès TIXIER to the Supervisory Board	19-03-19	CI
VALBIOTIS Names Murielle Cazaubiel as Director of Development and Medical Affairs	19-02-04	CI
Valbiotis Appoints Josep Infesta, International Expert in Consumer Healthcare, Head of Global Business Development	19-01-24	CI
VALBIOTIS Announces the Appointment of Murielle Cazaubiel as Director of Development and Medical Affairs	18-10-08	CI
VALBIOTIS Appoints Pascal Sirvent to its Board of Directors	18-08-30	CI
VALBIOTIS Appoints Cécile Merle to the Position of Quality Assurance Director	18-06-19	CI
Valbiotis Appoints Christine Roy-Duval as Director of Development and Medical Affairs	18-03-21	CI
VALBIOTIS Appoints Jean Zetlaoui on Valbiotis to Supervisory Board	17-09-20	CI
VALBIOTIS: Pascal SIRVENT Appointed Director of Discovery and Preclinical Research	17-09-14	BU
Valbiotis SA Appoints Pascal SIRVENT as Director of Discovery and Preclinical Research	17-09-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW